Nexviadyme 100 mg, poudre pour solution à diluer pour perfusion

7680678710031 CH-67871 Puder
Nexviadyme 100 mg, poudre pour solution à diluer pour perfusion
Nexviadyme 100 mg, poudre pour solution à diluer pour perfusion
Nexviadyme 100 mg, poudre pour solution à diluer pour perfusion
1 / 3
google

Article details

Package size
10
Selling units
10
Measure
Durchstechflasche(n)
Galenic form
Puder
Galenic group
Spray/Puder

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
30/09/2024
Summary of Product Characteristics
Français
30/09/2024
Summary of Product Characteristics
Italien
30/09/2024

Detailed composition

Substance Quantity Type Category
(N/A)
100.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Authorization holder

Sanofi-Aventis (Suisse) SA

1214 Vernier

Authorization information

Swissmedic authorization number
67871
Drug name
Nexviadyme, poudre pour solution à diluer pour perfusion
Galenic form
PULPI
ATC Code
A16AB22
Authorization status
Z
Dispensing category
A
First authorization
17/11/2021
Authorization expiration date
16/11/2026
IT Number
07.14.0.
Domain
Human medicine

Package details

Description (FR)
NEXVIADYME subst sèche 100 mg flac 10 pce
Description (DE)
NEXVIADYME Trockensub 100 mg Durchstf 10 Stk
Market launch
17/11/2021
Narcotic (BTM)
No

Other package sizes (2)

NEXVIADYME subst sèche 100 mg flac
1 DUR
GTIN: 7680678710017
View
NEXVIADYME subst sèche 100 mg flac 5 pce
5 DUR
GTIN: 7680678710024
View